Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
用户EO9nReo4Hj6s
2个月前
75
10
已完结
1. 系统已在2025-12-18 16:40:18对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s1470-2045(25)00594-7
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204525005947
其他信息:
出版社: Elsevier BV
作者: Yi-Long Wu; Yu Yao; Jin-Ji Yang; Lin Wu; Wei Zhang; Ying Wang; Hai-Peng Xu; Yong Song; Yan Zhang; Jun Zhao; Jing-Hua Chen; Zhe-Hai Wang; Qi-Ming Wang; Jie Hu; Xing-Ya Li; Yun Fan; Yuan Chen; Jian Fang; Di Han; Wei-Zhe Xue; Si-yang Maggie Liu; Qing Zhou; Pei-Long Zhang; He-Peng Shi
